August 20, 2003.ppt

Focus Area 14:Immunization and Infectious Diseases Progress Review August 20, 2003 Immunization and Infectious Disease Objectives Immunization objectives 14-23 Vaccination in day care, grades K and 1 14-24 Fully immunized children Plus others on Disease prevalence Children and vaccination Provider practice Immunization registries High-risk adults Adverse events Vaccine safety Immunization and Infectious Disease Objectives Infectious Disease objectives 14-10 Identification of persons with chronic Hepatitis C. 14-15 Prevention services for International travelers. Plus others on Hepatitis A, B, and C Bacterial meningitis Peptic ulcer hospitalizations Pneumococcal infections Antibiotics use Meningococcal disease Hospital-acquired infections Lyme disease Anti-microbial use in ICU’s Group B streptococcal disease . Immunization and Infectious Disease Objectives Tuberculosis objectives Tuberculosis Curative therapy for tuberculosis Treatment for high-risk persons Timely laboratory confirmation Morbidity Profile Universally Recommended Vaccination Coverage Among Children 19-35 Months, 2002 Universally Recommended Vaccination Coverage Among Children 19-35 Months, 2002 Influenza Vaccination Coverage During the Past 12 Months, Among Adults 65 Years and Older Pneumococcal Vaccination Coverage Ever Received Among Adults 65 Years and Older Hepatitis B Incidence Hepatitis B Incidence Hepatitis B Incidence, 2001 Rates of Tuberculosis Proportion of Tuberculosis Patients Completing Curative Therapy Progress Review data and slides can be found on the web at: /nchs/hphome.htm 0 3 823 Congenital Rubella Syndrome 0 22 1,314 Tetanus 0 0 16,316 Polio (paralytic) 0 167 20,000 H. Influenzae, type b 0 14 47,745 Rubella 2,000 8,296 147,271 Pertussis 0 238 152,209 Mumps 0 1 175,885 Diphtheria 0 37 503,282 Measles Target 2000 cases Average prevalence 20th Cent. cases Di